UK firm Osborne Clarke (OC) has expanded into mainland China after adding Shanghai-based firm Zhang Yu & Partners to its international network.

This is the fourth base in Asia launched by OC in recent years. The firm set up shop in Singapore last year in association with OC Queen Street, launched in Hong Kong in 2015 in association with Koh Vass & Co, and opened in India in 2014 after forming a best friend relationship with BTG Legal.

Zhang Yu is being set up by OC’s China co-managing partners, Guohua Zhang and Steve Yu.

Yu was previously managing partner at the Shanghai office of U.S. firm Armstrong Teasdale. His practice encompasses M&A, business incorporation, international joint venture, technology licensing, franchising, business consolidation and restructuring, regulatory and compliance matters.

Zhang was most recently a consultant on secondment with Koh Vass. His practice areas include investment, cross-border M&A as well as general corporate and commercial advice in China.

Zhang Yu will initially be supported by six lawyers specialised in IT, data and employment law, and the firm will add more partners later this year. It will focus on opportunities for clients in the digital business and consumer products sectors, as well as offering cross-border advisory services for OC’s sector clients with requirements in mainland China.

Related Articles

高赢、普士高、Osborne Clarke等助力西班牙制药公司基立福收购天诚德国,掌握Biotest 90%以上股份(ZH/EN)

by Kristen Liu 刘诗宇 |

西班牙化学及制药公司基立福(Grifols)近日与中国企业科瑞集团旗下子公司天诚国际投资有限公司达成协议,以11亿欧元收购天诚(德国)医药控股有限公司全部股份。普士高律师事务所、Osborne Clarke为基立福提供法律意见 ;高赢律师事务所则担任天诚德国律师。

Osborne Clarke enters China via tie-up with Shanghai's Zhang Yu

by John Kang |

UK firm Osborne Clarke (OC) has expanded into mainland China after adding Shanghai-based firm Zhang Yu & Partners to its international network.

君合、国枫助力2020全球血液制品市场最大并购交易(ZH/EN)

欧洲血浆制品生产商基立福(Grifols)以跨境换股方式战略投资A股上市公司上海莱士项目完成交割,君合律师事务所、Osborne Clarke律师事务所及普士高律师事务所代表基立福参与交易,国枫律师事务所则为上海莱士提供了法律意见。